101 related articles for article (PubMed ID: 1659849)
21. [Irinotecan plus cisplatin for the treatment of advanced non-small cell lung cancer].
Zhang XR; Zhu YZ; Xiu QY; Han FC; Liu DQ; Chu DT
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):777-9. PubMed ID: 17366795
[TBL] [Abstract][Full Text] [Related]
22. Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
Khuri FR; Rigas JR; Figlin RA; Gralla RJ; Shin DM; Munden R; Fox N; Huyghe MR; Kean Y; Reich SD; Hong WK
J Clin Oncol; 2001 May; 19(10):2626-37. PubMed ID: 11352954
[TBL] [Abstract][Full Text] [Related]
23. Docetaxel and cisplatin as second-line chemotherapy for advanced non-small cell lung cancer.
Hamada H; Irifune K; Ito R; Sakai K; Kadowaki T; Katayama H; Abe M; Shiode M; Nishimura K; Higaki J
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1235-9. PubMed ID: 17687204
[TBL] [Abstract][Full Text] [Related]
24. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
Fan Y; Huang ZY; Zhang YP; Sun L
Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancer.
O'Dwyer PJ; Langer CJ; Walczak J; Levy MH; Padavic-Shaller K; Hudes GR; Litwin S; Comis RL
Eur J Cancer; 1991; 27(12):1589-93. PubMed ID: 1664216
[TBL] [Abstract][Full Text] [Related]
26. Phase I study of oral teniposide (VM-26).
Smit EF; Ousterhuis BE; Berendsen HH; Sleijfer DT; Postmus PE
Semin Oncol; 1992 Apr; 19(2 Suppl 6):35-9. PubMed ID: 1329226
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
28. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study.
Graziano SL; Herndon JE; Richards F; DiFino S; Modeas C; Duggan DB; Green MR
Cancer; 1993 Jul; 72(1):62-8. PubMed ID: 8389667
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center.
Joss RA; Bürki K; Dalquen P; Schatzmann E; Leyvraz S; Cavalli F; Ludwig C; Siegenthaler P; Alberto P; Stahel R
Cancer; 1990 Jun; 65(11):2426-34. PubMed ID: 2159837
[TBL] [Abstract][Full Text] [Related]
30. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
31. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
Shepherd FA; Evans WK; Goss PE; Latreille J; Logan D; Maroun J; Stewart D; Warner E; Paul K
Semin Oncol; 1992 Feb; 19(1 Suppl 1):54-8. PubMed ID: 1329213
[TBL] [Abstract][Full Text] [Related]
32. Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
Song SY; Kim WS; Kim K; Jung CW; Im YH; Kim HJ; Kang WK; Lee HG; Kwon OJ; Rhee CH; Park CH; Park K
Jpn J Clin Oncol; 2003 Oct; 33(10):509-13. PubMed ID: 14623918
[TBL] [Abstract][Full Text] [Related]
33. First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.
Georgoulias V; Androulakis N; Dimopoulos AM; Kourousis C; Kakolyris S; Papadakis E; Apostolopoulou F; Papadimitriou C; Vossos A; Agelidou M; Heras P; Tzannes S; Vlachonicolis J; Mavromanolakis E; Hatzidaki D
Ann Oncol; 1998 Mar; 9(3):331-4. PubMed ID: 9602269
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy.
Williams CJ; Woods R; Levi J; Page J
Semin Oncol; 1988 Dec; 15(6 Suppl 7):58-61. PubMed ID: 2851181
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results.
Gottfried M; Ramlau R; Krzakowski M; Ziolo G; Olechnowicz H; Koubkova L; Dahabreh J; Szczesna A; Vivanco GL; Perng RP; Carpagnano F; Leong SS; Fittipaldo A; De Almeida C; Aubert D; Grunenwald D
J Thorac Oncol; 2008 Feb; 3(2):152-7. PubMed ID: 18303436
[TBL] [Abstract][Full Text] [Related]
36. High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung cancer.
Blumenreich MS; Woodcock TM; Gentile PS; Barnes GR; Jose B; Sherrill EJ; Richman SP; Epremian BE; Kubota TT; Allegra JC
J Clin Oncol; 1987 Nov; 5(11):1725-30. PubMed ID: 2824706
[TBL] [Abstract][Full Text] [Related]
37. A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer.
Hotta K; Sekine I; Tamura T; Sawada M; Watanabe H; Kusaba H; Akiyama Y; Inoue A; Shimoyama T; Nokihara H; Ueda Y; Yamamoto N; Kunitoh H; Ohe Y; Kodama T; Saijo N
Jpn J Clin Oncol; 2001 Dec; 31(12):596-600. PubMed ID: 11902490
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of non small cell lung cancer. A prospectively randomized study of cisplatin-etoposide versus cisplatin-mitomycin-vinblastine.
Polyzos A; Tsavaris N; Veslemes M; Dardoufas K; Dosios T; Kosmas C
J Chemother; 1997 Apr; 9(2):102-5. PubMed ID: 9176747
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness of combination chemotherapy with cisplatinum and etoposide in the treatment of advanced non-small cell lung cancer.
Gebbia V; Palmeri S; Russo A; Gebbia N; Rausa L
J Chemother; 1989 Jun; 1(3):203-6. PubMed ID: 2552031
[TBL] [Abstract][Full Text] [Related]
40. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
